Friedenthal Financial Decreases Holdings in Astera Labs, Inc. $ALAB

Friedenthal Financial reduced its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 55.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,038 shares of the company’s stock after selling 6,217 shares during the period. Friedenthal Financial’s holdings in Astera Labs were worth $986,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of ALAB. Fred Alger Management LLC grew its position in Astera Labs by 13.0% in the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock valued at $93,087,000 after acquiring an additional 179,638 shares in the last quarter. Hoey Investments Inc. lifted its position in shares of Astera Labs by 22.4% during the second quarter. Hoey Investments Inc. now owns 6,121 shares of the company’s stock worth $553,000 after purchasing an additional 1,121 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its stake in shares of Astera Labs by 21.6% in the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock valued at $1,336,000 after purchasing an additional 2,624 shares during the period. Wealth Effects LLC acquired a new stake in Astera Labs during the 2nd quarter valued at $242,000. Finally, Maryland State Retirement & Pension System increased its stake in Astera Labs by 37.7% during the 2nd quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company’s stock worth $629,000 after buying an additional 1,906 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on ALAB shares. Stifel Nicolaus upped their price objective on shares of Astera Labs from $185.00 to $200.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. JPMorgan Chase & Co. increased their price target on Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Barclays restated an “equal weight” rating and set a $155.00 price objective on shares of Astera Labs in a research note on Monday, October 20th. Wall Street Zen lowered Astera Labs from a “buy” rating to a “hold” rating in a research report on Tuesday, November 11th. Finally, CICC Research started coverage on Astera Labs in a research note on Friday, August 29th. They set an “outperform” rating and a $190.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $188.17.

Insider Activity

In other Astera Labs news, CEO Jitendra Mohan sold 90,459 shares of the stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the sale, the chief executive officer directly owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. This represents a 4.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Manuel Alba sold 150,000 shares of the firm’s stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the completion of the transaction, the director owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. The trade was a 8.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 586,936 shares of company stock valued at $89,331,140 over the last quarter. 12.50% of the stock is owned by company insiders.

Astera Labs Stock Down 2.2%

NASDAQ:ALAB opened at $168.83 on Wednesday. The company has a market cap of $28.52 billion, a PE ratio of 152.10, a P/E/G ratio of 3.22 and a beta of 1.51. The business’s 50 day moving average is $159.33 and its two-hundred day moving average is $157.03. Astera Labs, Inc. has a 52 week low of $47.13 and a 52 week high of $262.90.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The business had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. During the same period in the previous year, the business earned $0.23 EPS. The business’s quarterly revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.